Direct oral anticoagulants for the prevention of thromboembolic complications of atrial fibrillation: The more you pay, the less you spend?

被引:1
|
作者
Brunetti, Natale Daniele [1 ]
De Gennaro, Luisa [2 ]
Caldarola, Pasquale [2 ]
Gaglione, Antonio [1 ]
Di Biase, Matteo [1 ]
机构
[1] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy
[2] Osped San Paolo, Cardiol Dept, Bari, Italy
关键词
Direct oral anticoagulants; Cost effectiveness analysis; Budget impact analysis; Break even point; COST-EFFECTIVENESS; WARFARIN; MANAGEMENT;
D O I
10.1016/j.ijcard.2017.03.059
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:238 / 240
页数:3
相关论文
共 50 条
  • [31] INDIRECT TREATMENT COMPARISON (ITC) OF NOVEL ORAL ANTICOAGULANTS FOR THE PREVENTION OF THROMBOEMBOLIC EVENTS IN PATIENTS WITH ATRIAL FIBRILLATION
    Pechlivanoglou, P.
    Le, H. H.
    Engelfriet, P. M.
    Redekop, W. K.
    Postma, M. J.
    VALUE IN HEALTH, 2012, 15 (07) : A363 - A364
  • [32] Use of direct oral anticoagulants for stroke prevention in elderly patients with nonvalvular atrial fibrillation
    Oertel, Lynn B.
    Fogerty, Annemarie E.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2017, 29 (09) : 551 - 561
  • [33] Direct Oral Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation and Bioprosthetic Heart Valves
    Jain, Vardhmaan
    Bhatia, Kirtipal
    Aggarwal, Devika
    Bansal, Agam
    Narasimhan, Bharat
    Hendrickson, Michael J.
    Arora, Sameer
    Ricciardi, Mark J.
    Qamar, Arman
    STRUCTURAL HEART-THE JOURNAL OF THE HEART TEAM, 2021, 5 (06): : 631 - 633
  • [34] Efficacy and safety of direct oral anticoagulants (DOACs) for the secondary stroke prevention in atrial fibrillation
    Sakiyama, Y.
    Sanayama, H.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2017, 381 : 988 - 988
  • [35] Uncovering the Role of Direct Oral Anticoagulants in Stroke Prevention for Atrial Fibrillation: A Review of the Literature
    Rao, Sudipta
    Aggarwal, Shailesh
    Mani, Sweatha
    Balasubramanian, Abirami
    Veluswami, Keerthana
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [36] Direct oral anticoagulants for secondary prevention in patients with non-valvular atrial fibrillation
    Masotti, Luca
    Di Napoli, Mario
    Ageno, Walter
    Imberti, Davide
    Becattini, Cecilia
    Paciaroni, Maurizio
    Godoy, Daniel Augustin
    Cappelli, Roberto
    Landini, Giancarlo
    Panigada, Grazia
    Iori, Ido
    Prisco, Domenico
    Agnelli, Giancarlo
    ITALIAN JOURNAL OF MEDICINE, 2013, 7 : 8 - 21
  • [37] Occult gastrointestinal disease unmasked by direct oral anticoagulants used for the prevention of atrial fibrillation
    Colin, Luis
    Marquez, Manlio F.
    ARCHIVOS DE CARDIOLOGIA DE MEXICO, 2018, 88 (02): : 161 - 162
  • [38] Direct oral anticoagulants for Japanese atrial fibrillation in the elderly
    Kondo, Yusuke
    Senoo, Keitaro
    Kobayashi, Yoshio
    JOURNAL OF CARDIOLOGY, 2018, 71 (3-4) : 323 - 324
  • [39] Improving the use of direct oral anticoagulants in atrial fibrillation
    Di Minno, Giovanni
    Russolillo, Anna
    Gambacorta, Carminio
    Di Minno, Alessandro
    Prisco, Domenico
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2013, 24 (04) : 288 - 294
  • [40] Outcomes of Direct Oral Anticoagulants with Aspirin Versus Warfarin with Aspirin for Atrial Fibrillation and/or Venous Thromboembolic Disease
    Schaefer, Jordan K.
    Errickson, Josh
    Kong, Xiaowen
    Alexander-Souphis, Tina
    Ali, Mona A.
    Edupuganti, Subhash
    Haymart, Brian
    Kaatz, Scott
    Kline-Rogers, Eva
    Kozlowski, Jay H.
    Krol, Gregory D.
    Shah, Vinay
    Sood, Suman L.
    Froehlich, James B.
    Barnes, Geoffrey D.
    BLOOD, 2021, 138